The assessment, planning, and series of medical procedures necessary to preserve or restore a person's ventilation, or breathing, are referred to as airway management. Air can enter the lungs from the nose and mouth by keeping the airway open. For clinicians to be effective in life-or-death situations, they must possess the fundamental knowledge of airway management. Lack of airway control in circumstances where it might be necessary can result in individuals' blood oxygen levels being reduced, which is potentially fatal. Thus, in such situations airway management devices are used. The different types of medical devices used to maintain or open an individual’s airway include the oropharyngeal airway (OPA), nasopharyngeal airway (NPA), and endotracheal airway (ETA) and others.
Global airway management devices market is estimated to be valued at US$ 1,825.4 million in 2022 and is expected to exhibit a CAGR of 6.8% during the forecast period (2022-2030).
Figure 1. Global Airway Management Devices Market Share (%), by Device Type, 2022
Global Airway Management Devices Market- Drivers
The global airway management devices market is primarily driven by increasing product launches by key market players which in turn increases demand for airway management devices during the forecast period. For instance, in July 2021, Vyaire Medical, Inc., a medical device manufacturing company, launched AirLife Open oxygen mask, which have advanced design and airway management technology.
Increasing prevalence of chronic respiratory disease among the global population is expected to increase the growth of the global airway management devices market during the forecast period. For instance, the National Health Service stated that approximately 1.17 million people in the U.K. were diagnosed with chronic obstructive pulmonary disease (COPD) in 2021, which comprises of approximately 1.9% of the total population.
|Base Year:||2021||Market Size in 2022:||US$ 1,825.4 Mn|
|Historical Data for:||2017 to 2020||Forecast Period:||2022 to 2030|
|Forecast Period 2022 to 2030 CAGR:||6.8%||2030 Value Projection:||US$ 3,080.7 Mn|
Medtronic PLC, ICU Medical, Inc., Viggo Medical Devices, Teleflex Incorporated, Olympus America, Polymedicure, Ambu A/S., Verathon Inc., SourceMark, SunMed, KARL STORZ, Flexicare (Group) Limited, and Vyaire Medical
|Restraints & Challenges:||
Figure 2. Global Airway Management Devices Market Share (%), by Region, 2022
Global Airway Management Devices Market– Impact of Coronavirus (COVID-19) Pandemic
Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 100 countries across the globe and the World Health Organization had declared it a public health emergency on January 30, 2020.
COVID-19 has affected the economy in three main ways: by directly affecting production and demand of drugs and vaccines, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to nationwide lockdowns, several countries, such as China, India, Saudi Arabia, U.A.E., Egypt, and others, faced problems with regard to the transportation of drugs and vaccines from one place to another.
However, the COVID-19 pandemic had a positive impact on the global airway management devices market due to the increase in the respiratory related diseases such as chronic obstructive pulmonary disease (COPD), asthma etc. Moreover, due to Covid-19 virus outbreak, large number of people are suffering from coronavirus and this is expected to drive the market growth during the forecast period.
Global Airway Management Devices Market: Key Developments
In January 2019, Oventus Medical, a medical device company, released a new product, O2 Vent Optima. It is used in the obstructive sleep apnea disorder. It is designed on the basis of Oventus Medical’s airway technology. It prevents collapsing of airway and unobstructed airflow from tongue, soft palate, and nose. It can be used with or without continuous positive airway pressure
Global Airway Management Devices Market: Restraint
Increasing product recalls by the market players is expected to hamper the growth of the market over the forecast period. For instance, on August 29, 2022, the U.S. Food and Drug Administration announced that Philips Respironics (Philips) recalled certain bi-level positive airway pressure (also known as Bilevel PAP, BiPAP, or BPAP) machines as it was found that the machine was contaminated with plastic of a non-compatible material. If that plastic gets accumulated in the device motor, it may release certain chemicals of concern called volatile organic compounds (VOCs). The plastic may also cause the machine to fail and stop working suddenly during use.
Global Airway Management Devices Market- Key Players
Major players operating in the global airway management devices market include Medtronic PLC, ICU Medical, Inc., Viggo Medical Devices, Teleflex Incorporated, Olympus America, Polymedicure, Ambu A/S., Verathon Inc., SourceMark, SunMed, KARL STORZ, Flexicare (Group) Limited, and Vyaire Medical
Airway management is the assessment, planning, and series of medical procedures required to maintain or restore an individual’s ventilation, or breathing. By maintaining an open airway, air can flow from the nose and mouth into the lungs. Airway management is an essential skill for clinicians in critical situations and is fundamental to the practice of emergency medicine. Lack of airway control in circumstances where it might be necessary can result in individuals' blood oxygen levels being reduced, which is potentially fatal.
Airway management may be required for individuals in a variety of circumstances, ranging from simple choking to complicated airway obstruction. Airway obstruction most commonly occurs as a result of the tongue or foreign bodies blocking the airway. It can also be the result of injury to the airway, increased presence of blood and secretions (e.g., saliva and mucus), or inflammation of the airway.
This high prevalence coupled with an increase in anesthesia usage, due to an increase in surgeries, is expected to propel the demand for advanced devices, thus, expected to have a positive impact on the overall market growth. The increasing need for emergency treatment for prolonged illnesses as well as protracted treatments associated with lung diseases in children and adults is expected to drive the market growth. Moreover, increasing prevalence of chronic respiratory disease among the global population is expected to increase the growth of the global airway management devices market during the forecast period. For instance, according to the World Health Organization (WHO), chronic obstructive pulmonary disease (COPD) is the third leading cause of death globally. In 2019, it is estimated that 3.23 million people were suffering from COPD globally. Moreover, as per the Office of Disease Prevention and Health Promotion, It is estimated that, 14.8 million adults in the U.S. were diagnosed with COPD in 2020.
Key features of the study:
“*” marked represents similar segmentation in other categories in the respective section.